Medindia

X

IRIDEX Announces First Quarter 2010 Conference Call and Release Date

Thursday, April 29, 2010 General News J E 4
Advertisement


MOUNTAIN VIEW, Calif., April 29 IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release its first quarter 2010 financial results after the market closes on Thursday, May 6, 2010. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, May 6, 2010 to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by dialing (888) 549-7880 U.S. or (480) 629-9867 (International) and quoting Conference ID 4291498, or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Thursday, May 6, 2010 through Thursday, May 13, 2010 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4291498.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.

SOURCE IRIDEX Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Osseon Therapeutics Demonstrates to the European M...
S
Sarcoma Foundation of America Announces 11 New Res...